Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennon Regulatory News (PNN)

Share Price Information for Pennon (PNN)

Share Price is delayed by 15 minutes
Get Live Data
513.00    9.50 (1.89%)
Bid:
509.00
Ask:
509.50
Spread: 0.50 (0.098%)
Market Cap: £2.42b
PNN Live PriceLast checked at - London Stock Exchange

Intraday Pennon Share Chart

Share Repurchase Programme

30 Sep 2021 07:00

RNS Number : 4565N
Pennon Group PLC
30 September 2021
 

 

 

NOTIFICATION OF SHARE REPURCHASE PROGRAMME

 

 

30 September 2021

 

Pennon Group plc

Share Repurchase Programme

 

As detailed in Pennon's Trading Update on 28 September 2021, and in line with the package of shareholder returns announced by Pennon in June 2021 which was approved by shareholders at the General Meeting in June, authority was granted for the proposed on-market share buy-back programme (the "Programme") in respect of its ordinary shares of 61.05 pence each, of up to c.£400 million.

 

The purpose of the Programme is to reduce share capital, and completion of the Programme is subject to to Pennon's continued review of value creating opportunities in the UK water sector. The maximum number of shares that can be repurchased in connection with the Programme is 42,183,689 (being the maximum authority granted by shareholders at Pennon's AGM on 22 July 2021).

 

The first phase of the Programme commenced on 23 July and concluded on 10 September 2021, with c.£60 million deployed. Following on from this, Pennon is announcing today that it is initiating the second phase of the Programme and has entered into a non-discretionary agreement with Morgan Stanley & Co. International plc ("Morgan Stanley") to enable Morgan Stanley, acting as principal, to purchase ordinary shares of 61.05 pence each in the share capital of Pennon for an aggregate purchase price of no greater than £60 million and the simultaneous on-sale of such shares by Morgan Stanley to Pennon. This agreement commences on 30 September 2021 and share purchase activity pursuant to the agreement is expected to end no later than 26 November 2021. Morgan Stanley will make trading decisions in relation to Pennon shares purchased under the Programme independently of, and uninfluenced by, Pennon. All shares repurchased will be cancelled.

 

Further phases are expected to commence over the period to 30 September 2022.

 

Any purchase of Pennon shares done in relation to this announcement will be carried out on the London Stock Exchange and Multilateral Trading Facilities, as defined by the Directive 2014/65/EU on markets in financial instruments (including the delegated and implementing acts adopted under it) as implemented, retained, amended, extended, re-enacted or otherwise given effect in the United Kingdom from 1 January 2021 and as amended or supplemented in the United Kingdom thereafter, and executed within the price and volume conditions set out in the Listing Rules, the provisions of Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018), the Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) dealing with buyback programmes and the Company's general authority to make market purchases of Pennon shares granted at its AGM on 22 July 2021.

 

The Company will announce any market repurchase of shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred.

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

For further information, please contact:

Pennon Group plc

 

+44 (0) 1392 443 168

Paul Boote

Group Finance Director

Jennifer Cooke

Group Investor Relations Manager

 

Media Enquiries - Finsbury Glover Hering

 

 

+44 (0) 20 7251 3801

James Murgatroyd

Harry Worthington

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSDKCBKFBKDPCB
Date   Source Headline
1st Jun 20267:00 amRNSTotal Voting Rights
29th May 20262:06 pmRNSHolding(s) in Company
20th May 20261:48 pmRNSDirector/PDMR Shareholding
14th May 202612:03 pmRNSDirector/PDMR Shareholding
6th May 20262:12 pmRNSAdmission to Trading
1st May 20264:31 pmRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights
30th Apr 20263:11 pmRNSHolding(s) in Company
27th Apr 20264:34 pmRNSHolding(s) in Company
24th Apr 20263:29 pmRNSHolding(s) in Company
22nd Apr 20264:30 pmRNSHolding(s) in Company
21st Apr 20261:17 pmRNSDirector/PDMR Shareholding
20th Apr 20264:09 pmRNSHolding(s) in Company
14th Apr 20264:24 pmRNSRescheduled Full-Year Results Date
1st Apr 20267:00 amRNSTotal Voting Rights
20th Mar 20262:06 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTrading Statement
2nd Mar 20267:00 amRNSTotal Voting Rights
23rd Feb 202612:58 pmRNSDirector/PDMR Shareholding
10th Feb 20267:00 amRNSConfirmation of Chief Executive Officer Start Date
5th Feb 202610:58 amRNSHolding(s) in Company
2nd Feb 20267:01 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSBlock listing Interim Review
23rd Jan 20263:21 pmRNSDirector/PDMR Shareholding
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
23rd Dec 20253:29 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:29 pmRNSDirector/PDMR Shareholding
11th Dec 20251:16 pmRNSConfirmed Financial Calendar
9th Dec 20254:01 pmRNSDirector/PDMR Shareholding
9th Dec 20257:00 amRNSPennon Group CEO Transition Arrangements
1st Dec 20253:42 pmRNSEMTN: Publication of Supplementary Prospectus
1st Dec 20257:00 amRNSTotal Voting Rights
27th Nov 20257:00 amRNSHalf Year Results 2025/26
21st Nov 20254:24 pmRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNSTotal Voting Rights
22nd Oct 20251:26 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSPennon appoints new Non-Executive Director
3rd Oct 20252:19 pmRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSPennon Group appoints Keith Haslett as new CEO
1st Oct 20257:00 amRNSTotal Voting Rights
26th Sep 20257:00 amRNSTrading Statement
23rd Sep 20254:16 pmRNSDirector/PDMR Shareholding
11th Sep 202512:09 pmRNSEMTN Programme: Publication of Final Terms
1st Sep 20257:00 amRNSTotal Voting Rights
28th Aug 20252:44 pmRNSDirector/PDMR Shareholding
22nd Aug 20259:41 amRNSEMTN Programme: Publication of Base Prospectus
20th Aug 20254:15 pmRNSDirector/PDMR Shareholding
1st Aug 20257:01 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.